Fisher, A.B.; Dodia, C.; Chatterjee, S.; Feinstein, S.I.
Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395. Int. J. Mol. Sci. 2020, 21, 398.
https://doi.org/10.3390/ijms21020398
AMA Style
Fisher AB, Dodia C, Chatterjee S, Feinstein SI.
Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395. International Journal of Molecular Sciences. 2020; 21(2):398.
https://doi.org/10.3390/ijms21020398
Chicago/Turabian Style
Fisher, Aron B., Chandra Dodia, Shampa Chatterjee, and Sheldon I. Feinstein.
2020. "Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395" International Journal of Molecular Sciences 21, no. 2: 398.
https://doi.org/10.3390/ijms21020398
APA Style
Fisher, A. B., Dodia, C., Chatterjee, S., & Feinstein, S. I.
(2020). Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395. International Journal of Molecular Sciences, 21(2), 398.
https://doi.org/10.3390/ijms21020398